NCT02283281View on ClinicalTrials.gov

Anesthetic Premedication With a Cannabis Extract (Cannapremed)

PHASE2/PHASE3RecruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
Pain, PostoperativePostoperative Nausea and VomitingAnxiety
Interventions
DRUG

Tetrahydrocannabinol

1:1 THC to CBD standardized extract from cannabis plant

DRUG

Dummy oromucosal

drops containing only Olive oil vehicle without the active compound (i.e.: without Cannabis oil)

Trial Locations (1)

12000

RECRUITING

Hasassah - Hebrew University Ein Kerem Medical Center, Jerusalem

Sponsors

Collaborators (1)

Jazz Pharmaceuticals
All Listed Sponsors
collaborator

Jazz Pharmaceuticals

INDUSTRY

lead

Hadassah Medical Organization

OTHER